TNNT2 and familial dilated cardiomyopathy: These include several prior validated targets affected in DCM patients with the RBM20 S635A mutation, such as TTN, CAMK2D, OBSCN, RYR2, IMMT, and TNNT2 (Fig. 4b–d, and Supplementary Fig. 5b)16.